# To Evaluate the Efficacy and Safety of Balloon Catheter Combined With Oxytocin Induction in Nulliparous Women With Estimated Fetal Weight ≥3500g at 39-40 Weeks of Gestation

> **NCT05197101** · NA · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 150 (estimated)

## Conditions studied

- Macrosomia, Fetal

## Interventions

- **PROCEDURE:** balloon catheter combined with oxytocin induction

## Key facts

- **NCT ID:** NCT05197101
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-17
- **Primary completion:** 2023-01-17
- **Final completion:** 2023-03-17
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05197101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05197101, "To Evaluate the Efficacy and Safety of Balloon Catheter Combined With Oxytocin Induction in Nulliparous Women With Estimated Fetal Weight ≥3500g at 39-40 Weeks of Gestation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05197101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*